Journal of Research in Medical Sciences is a leading open-access journal published by Wolters Kluwer Medknow Publications, dedicated to disseminating innovative research and advancements in the field of medicine. Established in 2005, the journal has earned a respectable Scopus rank of 205 out of 636 in General Medicine, placing it within the 67th percentile among its peers, indicative of its quality and influence in the field. With an Open Access policy adopted in 2015, the journal ensures that critical research findings are accessible to a global audience, thus fostering knowledge sharing and collaboration among researchers, medical professionals, and students. Operating out of Iran, the journal focuses on diverse aspects of medical science, offering a platform for emerging studies that span clinical practices to health-related outcomes. As a recognized publication in the Q3 quartile of medicine (miscellaneous) for 2023, the Journal of Research in Medical Sciences continues to play a pivotal role in promoting scholarly work and advancing medical knowledge, making it an essential resource for anyone invested in the evolution of healthcare and scientific inquiry.

American Journal of Epidemiology is a premier peer-reviewed journal published by Oxford University Press, focusing on the advancement of epidemiological knowledge and methodology since its inception in 1921. With an ISSN of 0002-9262 and E-ISSN 1476-6256, this influential journal serves as a vital resource for researchers and practitioners worldwide, highlighting significant epidemiological findings and fostering dialogue within the field. Ranked in the Q2 category of Epidemiology and holding a commendable 80th percentile in Scopus' ranking, the journal continues to play a significant role in shaping public health policies and practices. Although the journal is not open access, it remains accessible through institutional subscriptions, ensuring comprehensive discourse on pressing epidemiological issues. By continuously publishing high-quality research that informs disease prevention and control strategies, the American Journal of Epidemiology stands at the forefront of epidemiological inquiry, promoting improved health outcomes on a global scale.

Contemporary Clinical Trials Communications, published by ELSEVIER INC, serves as a pivotal resource in the evolving fields of medicine and pharmacology, especially with its commitment to open access since 2015. With the E-ISSN 2451-8654, this journal is dedicated to disseminating high-quality research that examines contemporary clinical trial methodologies and their applications in improving healthcare outcomes. Situated in the United States, its impressive ranking, with a Q2 status in both Medicine (miscellaneous) and Pharmacology for 2023, highlights its significance and impact within the scientific community. Ranking #199 out of 636 in General Medicine and #217 out of 313 in Pharmacology on the Scopus scale, the journal aims to foster innovative discussions and developments among researchers, professionals, and students, making it an essential tool for those seeking to stay at the forefront of clinical research and trials.

Open Medicine, with ISSN 2391-5463 and E-ISSN 2391-5463, is a distinguished peer-reviewed journal published by De Gruyter Poland Sp. z o.o, focusing on a broad array of topics in the field of medicine. Since its inception in 2013, the journal has maintained an Open Access policy, fostering the dissemination of scientific knowledge across global audiences and promoting collaborative research efforts. Based in Germany, Open Medicine has established itself within the medical community, achieving a respectable Q3 ranking in the category of Medicine (Miscellaneous) as of 2023, and placing in the 72nd percentile in general medicine according to Scopus rankings. The journal aims to bridge gaps in research by offering a platform for innovative studies, clinical trials, and comprehensive reviews that advance medical knowledge and practice. With a commitment to enhancing accessibility and visibility of research, Open Medicine plays a vital role in encouraging the continued development of the medical field, making it an essential resource for researchers, professionals, and students alike.

Lancet Gastroenterology & Hepatology is an esteemed journal, published by ELSEVIER INC in the United Kingdom, dedicated to advancing the fields of gastroenterology and hepatology. Since its inception in 2016, this journal has quickly established itself as a leading platform for high-quality research, evidenced by its impressive rankings as Q1 in both Gastroenterology and Hepatology for 2023. With a Scopus rank of #2 out of 167 in Gastroenterology and #2 out of 82 in Hepatology, it lies in the prestigious 99th and 98th percentiles, respectively, underscoring its significant impact within the scientific community. The journal aims to publish original research, critical reviews, and clinical studies that illuminate the latest advancements and challenges in the understanding and treatment of gastrointestinal and liver diseases. As a vital resource for researchers, healthcare professionals, and students alike, the Lancet Gastroenterology & Hepatology journal fosters the dissemination of pioneering findings and facilitates informed discussions to enhance patient care and health outcomes globally.

Trauma Monthly is a dedicated academic journal that focuses on the multifaceted issues surrounding trauma care, critical care, and emergency medicine. Published by the NATL CENTER TRAUMA RESEARCH in Iran, this journal has been contributing to the literature since 2011 and is poised to expand its reach until 2024. Despite its current categorization in the Q4 quartile across various medical fields including Critical Care, Emergency Medicine, and Surgery, Trauma Monthly is committed to addressing essential advancements and challenges in trauma research and clinical practice. The journal offers Open Access to its contents, making high-quality research accessible to a wider audience, thereby fostering collaborative efforts and interdisciplinary studies. With a growing impact within its designated fields, it aims to support researchers, medical professionals, and students in enhancing their understanding of trauma care and interventions. The ISSN for the journal is 2251-7464 and the E-ISSN is 2251-7472, marking it as a prominent source of information in its domain.

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

Welcome to the Journal of Evidence Based Medicine, a premier platform dedicated to advancing the field of health policy and medicine through rigorous research and scholarship. Published by WILEY, this esteemed journal, with an ISSN of 1756-5383 and E-ISSN 1756-5391, is headquartered in the United Kingdom and serves as a pivotal resource for disseminating high-quality evidence-based research. Operating within the converged years from 2008 to 2024, the journal boasts a remarkable standing, achieving a Q1 category ranking in both Health Policy and Medicine (Miscellaneous) for 2023, and ranking #12 out of 310 in the Scopus Ranks for Medicine & Health Policy, placing it in the 96th percentile. This commitment to excellence makes the journal a significant conduit for professionals, researchers, and students who seek to inform their practices with the latest evidence and foster advancements in health policy and medical practice. While currently not open access, the journal maintains a rigorous selection process to ensure the highest standards of publication, appealing to anyone intent on exploring groundbreaking studies that shape the health landscape globally.

Farmeconomia-Health Economics and Therapeutic Pathways is a pioneering journal within the field of health economics, dedicated to exploring the intersections of health policy, therapeutics, and economic evaluations. Published by SEED MEDICAL PUBLISHERS, this Open Access journal has been at the forefront of advancing knowledge since 2012, ensuring that vital research is readily accessible to a global audience without subscription barriers. The journal aims to facilitate the dissemination of insightful studies, systematic reviews, and theoretical discussions that determine the cost-effectiveness of therapeutic options, ultimately guiding evidence-based healthcare decisions. Based in *Torino, Italy*, this journal is committed to serving researchers, healthcare professionals, and students who are eager to contribute to and stay updated on the latest developments in health economics and policy implementation. With its broad-ranging scope and dedication to quality research, Farmeconomia stands as an essential resource for anyone engaged in the complex dynamics of health systems and their economic implications.

The Cochrane Database of Systematic Reviews is a premier journal published by WILEY, focusing on the critical appraisal and synthesis of high-quality research in health care. With its dedication to evidence-based practice, this journal serves as a cornerstone for researchers, healthcare professionals, and students alike, offering pivotal insights through rigorous systematic reviews. Although it is not an open-access publication, its influence in guiding clinical decision-making and policy formulation is profound, underscored by its contributions to the advancement of healthcare knowledge. Based in the United States at 111 River St, Hoboken, NJ, the Cochrane Database has established itself as essential reading for those seeking to stay at the forefront of systematic reviews and meta-analyses in the medical field, ensuring that users are well-equipped with the evidence necessary for informed practice.